FDA Approves Unknown Drug — SPECGX LLC
SpecGx LLC has received FDA approval for ANDA 219395, signaling an imminent opportunity for the company to enter the market with the companion diagnostic product. This regulatory m…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
SpecGx LLC has received FDA approval for ANDA 219395, signaling an imminent opportunity for the company to enter the market with the companion diagnostic product. This regulatory m…
Apotex has secured FDA approval for the generic version of tofacitinib (ANDA218096), slated for release on June 3, 2026, which is set to intensify commercial competition and exert …
# FDA Approves Generic Romidepsin from Amneal Pharmaceuticals Amneal Pharmaceuticals LLC has received FDA approval for generic romidepsin intravenous formulation, expanding the co…
Casper Pharma LLC has secured FDA approval for its generic drug application (NDA212927), slated for issuance on June 2, 2026. This regulatory clearance is expected to alter market …
# FDA Approves Zydus Pharmaceuticals' Generic Fluorescein Sodium Injection Zydus Pharmaceuticals USA Inc. received FDA approval for its generic fluorescein sodium intravenous inje…
Concord Biotech Ltd’s FDA approval of ANDA218566 is expected to enhance the company’s long-term market position and revenue potential, paving the way for strategic commercial activ…
Approval was granted by the FDA on June 1, 2026, to Jiangsu Anbison for ANDA219288, signaling a significant milestone in the company's commercial portfolio. This authorization is e…
# FDA Approves Hikma's Generic Drug Application Hikma Pharmaceuticals received FDA approval for ANDA 220562 on May 29, 2026, expanding its generic drug portfolio and positioning t…
Novadoz Pharmaceuticals announced the FDA approval of its oral oxcarbazepine tablets (ANDA 209020), a generic version of the anticonvulsant, which is expected to bolster the compan…
Shionogi Inc. announced FDA approval for the oral antiviral XOCOVA (ensitrelvir) effective May 29, positioning the company to expand its commercial footprint with a non-injectable …
**Flex Pharma received FDA approval for NDA217379 on May 29, 2026, a milestone anticipated to unlock significant commercial value and drive a material re-rating of the company’s ma…
HAISCO PHARMACEUTICAL GROUP CO LTD has received FDA approval for its unspecified New Drug Application, setting the stage for a pivotal product launch in May 2026 that is expected t…
# FDA Approves Lupin's Generic Drug Application Lupin Limited received FDA approval for its abbreviated new drug application (ANDA 216095), expanding the company's generic portfol…
The FDA approved Unknown Drug from BIOCON PHARMA under application ANDA220709 on 2026-05-28.
# FDA Approves ANDA for Somerset Therapeutics Somerset Therapeutics LLC has received FDA approval for an abbreviated new drug application (ANDA219529), expanding its generic drug …
Camber Pharmaceuticals Inc. won final FDA approval Tuesday for its generic 25-mg losartan potassium and hydrochlorothiazide tablets, completing a process that has allowed other gen…
Teva Pharmaceuticals USA announced the FDA approval of its generic product under ANDA208433 on May 27, 2026, marking a potential new entry into the market pending launch and impact…
On May 27, 2026, Abbott has received FDA approval for DECNUPAZ (pivekimab sunirine-pvzy), an intravenous therapy, indicating a potential expansion of AbbVie’s pipeline though the c…
Camber Pharmaceuticals received FDA approval for its oral L-Glutamine generic on May 26, 2026, positioning the company to compete in a high-volume therapeutic market. The launch is…
With the FDA approving its ANDA application on May 26, 2026, RICONPHARMA LLC is positioned to capture significant market share by launching a generic alternative immediately. This …